CCCC C4 Therapeutics, Inc.
Healthcare$3.56+1.14%ClosedMarket Cap: $294.9M
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$7.00
Target (Median)
$7.00
Target Range
$7.00 - $7.00
Upside from current price: 96.6%
Rating Distribution
1 Strong Buy7 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-02-27 | Barclays | maintain | Overweight | Overweight |
| 2026-02-23 | Brookline Capital | maintain | Buy | Buy |
| 2025-12-17 | Barclays | maintain | Overweight | Overweight |
| 2025-09-23 | Barclays | maintain | Overweight | Overweight |
| 2025-09-23 | Wells Fargo | maintain | Overweight | Overweight |
| 2025-09-22 | Stephens & Co. | maintain | Overweight | Overweight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-1.01 | $20.1M | 4 |
| Sun Dec 31 | $-1.19 | $18.3M | 6 |
| Mon Dec 31 | $0.16 | $531.8M | 4 |
| Tue Dec 31 | $3.44 | $1.78B | 2 |